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ABSTRACT
We describe a new method that allows cloning of
double-stranded RNAs (dsRNAs) that are generated
in RNase protection experiments. We demon-
strate that the mouse C/D box snoRNA MBII-85
(SNORD116) is processed into at least five shorter
RNAs using processing sites near known functional
elements of C/D box snoRNAs. Surprisingly, the ma-
jority of cloned RNAs from RNase protection experi-
ments were derived from endogenous cellular RNA,
indicating widespread antisense expression. The
cloned dsRNAs could be mapped to genome areas
that show RNA expression on both DNA strands and
partially overlapped with experimentally determined
argonaute-binding sites. The data suggest a con-
served processing pattern for some C/D box
snoRNAs and abundant expression of longer, non-
coding RNAs in the cell that can potentially form
dsRNAs.
INTRODUCTION
RNA:RNA interactions play an important role in gene re-
gulation, as shown by the recognition of pre-mRNA splice
sites by snRNPs, and the regulation of mRNA function by
miRNAs (1). All RNAs undergo extensive processing and
are typically generated from longer precursor molecules.
Recent high-throughput sequencing (HTS) data showed
that RNAs previously viewed as metabolically stable, such
as C/D and H/ACA snoRNAs as well as tRNAs undergo
further processing resulting in shorter RNA forms (2–8).
To fully understand how these RNAs are formed, it is
necessary to clone them. One of the most precise ways to
identify RNAs generated from a precursor RNA is
to employ RNase protection analysis using a radioactively
labelled antisense probe against the precursor.
Hybridization of the probe to its target strand generates
a dsRNA that is separated from other RNAs by removing
all single-stranded RNAs using RNases. This method is
well suited to study the processing of a defined larger
RNA into smaller fragments, as these fragments can be
detected by the shortening of the protected RNAs. RNase
protection experiments are well established to give
quantitative results.
Although RNase protection experiments are highly sen-
sitive and selective, their use is hampered by the inability
to directly clone the protected RNA fragments, which is
due to the lack of appropriate double-stranded RNAs
(dsRNA) modifying enzymes. Previously, only dsRNAs
from viruses that can be produced in large quantities
could be cloned (9) and cloning has been demonstrated
as a proof of principle using in vitro transcribed RNAs
and model viral dsRNAs (10).
To overcome this problem, we devised a technique to
clone dsRNAs from standard RNase protection reactions.
An overview of the method is given in Figure 1a. The
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method allows the identification of RNAs that are gene-
rated by processing of precursor RNAs. We were able
to establish the processing pattern of RNAs derived
from a C/D box snoRNA, MBII-85 (SNORD 116 in
humans). Unexpectedly, we found evidence for abundant
expression of endogenous RNAs that could form double
strands in vivo. These endogenous RNAs overlap with
genome regions that show evidence for expression of
(a)
(b)
Figure 1. Overview of the method. (a) Cloning steps. RNAs are shown as red lines, the synthetic antisense probe as a blue line. Short vertical lines
indicate hybridizations. (b) Overview of the primer locations prior to RT–PCR. Note that the 50 rApp residue is removed after ligating the linkers.
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RNAs from both DNA strands. Some of these potentially
dsRNA parts overlap with experimentally verified
RNA:miRNA interaction sites. The high abundance of
potential dsRNA sites indicates a biological role of
RNA expression derived from opposite DNA strands
that can be detected with this method.
MATERIAL AND METHODS
Cloning of dsRNAs
Probe synthesis. We synthesize two RNA probes, a low-
specific activity probe for cloning purposes and a high-
specific activity probe for detection of the RNAs. For
cloning purposes, we synthesize an antisense RNA using
all four cold NTPs at a concentration of 1 mM. To visual-
ize the RNA, we spike this RNA with 1 ml of 32P a-UTP
(800mCi/mM) in a 20 ml reaction. This generates a low-
specific activity probe of 0.6 108 cmp/mg. To detect
protected fragments, we synthesize one probe with
high-specific activity using radioactive 32P a-UTP as the
only source of UTP (specific activity 1.4 109 cmp/mg).
We use the megascript kit (Ambion) for RNA synthesis.
RNase protection. We incubate 100 mg total brain RNA
with 500 ng spiked antisense probe. The RNA is
prepared using trizol, to avoid loss of small RNAs. In a
parallel experiment, we incubate 10 mg total brain RNA
with 50 000 cpm of high-specific probe. Probes and cold
RNAs were precipitated, dissolved in hybridization buffer
and denatured at 95C for 3min. Hybridization is carried
out overnight, in 10 ml of hybridization buffer at 42C.
Single-stranded RNA is digested by RNase T1 and A1
in 150ml of RNase digestion buffer. Since both RNase A
and RNase T1 leaves a 30 phosphate, we treat the reaction
with shrimp nuclease for 300 in the same buffer to generate
a free 30OH group. Prior to proteinase K digestion, 15 mg
glycoblue (Ambion) is added.
Hybridization buffer: 40mM PIPES, 1mM EDTA,
400mM NaCl, 80% formamide, pH 6.4.
RNase digestion buffer: 300mM NaCl, 10mM Tris–Cl,
5mM EDTA, pH 7.4.
RNases removal. RNases are removed by adding 15 ml of
10mg/ml proteinase K and 15 ml of 10% SDS, followed by
one hour incubation at 37C and phenol/chloroform
extraction.
Removal of free nucleotides. Free nucleotides are removed
by running the protected RNAs over a 15–18% 8M Urea,
1 TBE gel. To later visualize the protected bands, we
combine the reactions made with the high- and low-
specific probes. After overnight autoradiography, the
bands are cut out from the gel and the fragments are re-
covered by soak–crush in 3M NH4Ac, 1% SDS solution
overnight at 37C. Fragments are recovered by adding
2.5 volume ethanol and 1 ml of glycoblue.
Addition of the 30 linker A. The linker A sequence is:
50rAppCTGTAGGCACCATCAAT/3ddC. The rAppC
moiety at its 50-end allows its ligation without ATP to
the 30 OH of a nucleic acid. Its 30-end is blocked by
inclusion of ddCTP. The first ligation is carried out in a
20 ml volume. The final concentration of linker A is 4 mM.
The ligation is carried out for 2 h in a 20 ml reaction in
50mM HEPES pH 8.3, 10mM MgCl2, 3.3mM DTT,
10 mg/ml BSA, (1 RNA ligation buffer, NEB), 8.3%
(v/v) glycerol, 10% PEG 5000 and 20U RNA ligase
(NEB).
50 phosphorylation and removal of linker. We phosphoryl-
ate the 50-ends using polynucleotide kinase (NEB) and
1mM ATP for 30min, followed by precipitation. The
phosphorylated RNA with the linker is again purified
over a 15% 8M Urea, 1 TBE gel. This step is necessary,
as otherwise, there are free nucleotides in the RNA
solution that react with the first linker and will result in
clones with 2- to 3-nt inserts. RNA is again recovered by
crush–soak and precipitation using glycoblue and NH4Ac.
Addition of the 50 linker B. The linker B sequence is
50-AmMC6/GCTCCAGAATTCGGACCCGArGrUrG
rCrCrUrArCrArG. The 50-end is blocked using AmMC6.
The second linker is added to the RNA at a concentra-
tion of 4 mM. Ligation is performed using T4 DNA ligase
at 20C overnight in 1 ligase buffer (NEB) that contains
ATP. The ligation mixture is precipitated and dissolved in
10 ml.
RT–PCR. Reverse transcription is done using monster
script (Epicenter), after denaturing the template for three
minutes at 95C. The reverse transcription is carried out
at 60C for 40 minutes, using primer reverse #1: 50
gattgatggtgcctacag. An aliquot (one-tenth) of the
reaction is spiked with 2 ml a-32P dCTP. The aliquot of
the cDNA is separated on a 15% acrylamide/8M urea gel
to monitor cDNA synthesis. The reverse transcription
mixture is then amplified by PCR using primers reverse
#1 and forward #1 (50GCTCCAGAATTCGGACCCGA
GTG-30).
PCR validation of potential dsRNA transcripts. Two sets
of primers were designed to test Dlgap2, Maml3, Kirrel3
and 2610528E23Rik genes, respectively. (Dlgap2: primer1
forward: TGTGCCTTCCGTGGTGTGCAGTTTAG,
reverse:TCTTCATTTCACCGAGAGTCACACAGG;
primer2 forward: GGGTGGCCGTCCATGACGTCCAGC
TTTG; reverse: CATCCACATACAGAACCTTCTGTCAC
C. Maml3: primer1 forward: ACACTGAGTTCTAGGAG
ATTCTCAGG, reverse: GTATCATATATTAGGCTGG
GTAAG; primer2 forward: TTGATCTTATCTTGTCAC
ATGATTTC, reverse: CAGTGCTCACAGACCCTG
AAGA. Kirrel3 primer1 forward: ACTCTCCTCTCCTC
TCCTCTCTCTG, reverse: CTCTCACTGAGGATCAA
GCTTGG; primer2 forward: CTAAGAACCACTCACA
GGCAGCCAC, reverse: GTGGACTGACTGGAGAGG
GAAGTC. 2610528E23Rik primer1 forward: CCCTGTA
ACGTGTCCCTGAATGTTACTC, reverse: GAGAGAT
TGTGCGTGACTGTTGGTAGG; primer2 forward: CT
TCCACCTATCCTACAGATACTACTGC, reverse: GC
CCTGTCTCGCAGACAGCGTATATTAC.). PCR was
performed using PlatinumTaq polymerase and
SuperScript III Reverse transcriptase (Invitrogen).
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Bioinformatic analysis
Mapping of SOLiD reads to the mouse genome. We started
with 47 755 454 Sequencing by Oligonucleotide Ligation
and Detection (SOLiDTM) reads of length 50. We used
bowtie (version 0.12.3) (http://bowtie-bio.sourceforge.
net/) (11) to align them to the mouse genome (NCBI37/
mm9). In order to account for the 50 adapter, which could
appear with variable length, we adopted a sequential
trimming strategy: we mapped the reads using various
trimmings at the 50-end: 23, 24, . . . , 29 nt, i.e. we
mapped reads of length 27, 26, . . . , 21. In each run, we
requested best match with no more than two mismatches
over the length of the read. Subsequently, for each original
read we kept the longest successful mapping, i.e. we keep
the first mapping such that the read had not been found in
any of the previous (shorter) trimming steps. This
produced a total of 22 216 961 uniquely mapped reads
on both strands (Supplementary Figure S2a). We then
clustered independently forward and reverse strand reads
using at least 1 nt overlap in the same strand
(Supplementary Figure S2b), obtaining 7 084 100 clusters
in forward and 7 087 115 clusters in reverse; 1 501 137 and
1 498 850 clusters with more than one read, respectively.
Comparison of SOLiD reads with genomic regions that
could express dsRNAs. To compare the read clusters
with the RefSeq annotation we used mm9, downloaded
from UCSC. For the initial 14 171 215 read clusters, we
found 3 212 152 (22.6%) to locate in a genic region, con-
sidered to be the extension from transcription start site
(TSS) to transcription termination site (TTS), which
were taken from the RefSeq annotation. As a comparison,
we found 80 672 (49.18%) of the candidate dsRNAs to
overlap with a genic region (Supplementary Figure S5).
This represents 2-fold enrichment. We also calculated
the expected gene loci positions as the union of forward
and reverse positions in gene loci (898 381 160 bp) and
compared it with the total number of base pairs in the
genome removing gaps (2 654 917 900 bp), which would
give an estimate of 35% of the base pairs in the genome
covered by genic regions. The total base pairs of candidate
dsRNA in genic regions (11 732 808 bp) represents 50% of
the total base pairs in candidate dsRNAs (23 430 566 bp).
Comparing the counts, we find a significant enrichment
(2=983 478, df=1, P< 2.2e16).
Calculation of dsRNA-expressing candidate regions. We
first calculated the pre-mRNA regions from the RefSeq
annotation that overlap with antisense transcripts,
i.e. other RefSeqs and spliced ESTs. We considered
only spliced ESTs, as intronless ESTs cannot always be
accurately assigned to the correct strand. We defined
each region as the genomic range of a pre-mRNA that
has evidence of transcription from the opposite strand.
We obtained a total of 35 916 different regions. We then
calculated the read-clusters that overlap with any of these
dsRNA-expressing candidate (DEC) regions. For this,
we removed all singletons, i.e. clusters with one single read.
Mapping of AGO HITS-CLIP reads. We downloaded
from http://ago.rockefeller.edu/ the reads from the
HITS-CLIP experiment for Ago (12) for the mouse neo-
cortex samples (A–E) separated into two fractions:
110 kDa (miRNA fraction) and 130 kDa (mRNA target
fraction). We then carried out, as above for the SOLiD
samples, a sequential trimming but this time from the
30-end, using trimmings from 0 to 11 bases in samples A
and B; and from 4 to 15 bases in samples C–E; hence, we
mapped lengths from 32 to 21 nt. We only kept unique
best matches allowing up to two mismatches. For each
original read, we kept the longest successful mapping,
i.e. the first map found in the sequential trimming. This
resulted in a total of 5 374 490 mapped reads for the
110-kDa fraction, forming 556 723 clusters; and
22 109 188 mapped reads for the 130-kDa fraction,
forming 1 091 734 clusters. These clusters were compared
with the 106 486 dsRNA candidates derived above that do
not fall in repeats, using the program fjoin (13). This
produced an overlap of 10 454 dsRNA clusters with
12 562 Ago target clusters and of 5665 dsRNA clusters
with 6029 Ago miRNA clusters.
RESULTS
Processing of MBII-85 and MBII-52
We recently found that the C/D box snoRNA MBII-52/
SNORD 115 is processed into smaller RNAs (3), which
were named psnoRNAs. MBII-52 is expressed from the
SNURF–SNRPN transcription unit that has been impli-
cated in the Prader-Willi syndrome. Figure 3a and b shows
a schematic overview of this unit for human and mouse.
Three patients with microdeletions in the SNURF–
SNRPN have been reported (14–16). Since these patients
exhibit a Prader-Willi syndrome-like phenotype, it is likely
that the disease-causing genes reside in this region. Two of
the microdeletions encompassed only the expression units
of snoRNAs HBII-85 (human SNORD 116) and half
of the HBII-52 copies. Each expression unit consists of
two non-coding exons that flank the intron that hosts
the snoRNA (schematically shown in Figure 2a). The
comparison of the three microdeletions (thick line in
Figure 3a) indicated that the absence of the human
ortholog of MBII-85 is likely the most important molecu-
lar cause for the Prader-Willi like phenotype.
We therefore investigated the processing pattern of the
mouse MBII-85 snoRNA. We analysed the copy that is
most closely related to human copy number 27 (genomic
coordinates of the expression unit consisting of snoRNA
and flanking exons is chr7:66 838 324–66 844 003 on
NCBI37/mm9). We used a probe complementary for
MBII-85 in an RNase protection assay and we detected
six fragments (a–f) in brain tissue (Figure 2B), indicating
that this snoRNA is processed, similar to MBII-52 (3).
Cloning of dsRNA
A graphic overview of the method is given in Figure 1a.
To identify the processing sites, we clone the fragments, as
outlined here and described in detail in the methods. First,
we perform a standard RNase protection assay using a uni-
formly labelled antisense RNA probe. For cloning, a
low-specificity probe is used (0.6 108 cmp/mg). An
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amount of 100 mg total mouse brain RNA were hybridized
overnight with 500 ng antisense probe using a commercial
RNase protection kit (Ambion). To better visualize the
protected fragments, we perform a parallel hybridization
with an antisense probe that was generated with
radiolabelled a-UTP as the only UTP source. After hy-
bridization, both reactions are mixed and further pro-
cessed together. Single-stranded RNA is removed by
(a)
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+
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Figure 2. Cloning steps in cloning dsRNAs. (a) Schematic representation of the MBII-85 expression cassette and the location of the antisense probe.
(b) RNase protection using MBII-85 as a probe and total mouse brain RNA as a target. The obtained bands are labelled a–f. M: 10-bp ladder
marker, P: probe, B: protection of brain RNA, Y: protection of yeast RNA. (c) Addition of the 30 linker_A. An aliquot of the protection reaction
was run in lane RPA, and the total reaction with the 30-end linker is run in lane RPA+ 30 linker. The addition of the linker caused a shift in the
dsRNA bands that is indicated by arrows. (d) cDNA synthesis. The representative gel shows the cDNA synthesis after ligation of the second linker.
a/b, c/d and e/f correspond to the cut out areas in panel c. (e) Colony hybridization of bacteria transformed with cloned dsRNAs from step (d).
A total of 100 bacterial clones were streaked out on an agar plate, lifted with a nitrocellulose filter and hybridized. Four end-labelled oligonucleotides
covering the MBII-85 sequence were used for hybridization. As shown here, only 10–20% of the obtained clones contained antisense probe sequences.
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RNase A1 and T1 digestion. For cloning, we dephos-
phorylate the RNAs with shrimp nuclease and depro-
teinate the reaction with proteinase K, followed by
phenol/chloroform extraction. This step is necessary to
prevent self ligation of the products. The reactions are
separated on 15% acrylamide 8M Urea/TBE gels and
visualized by autoradiography overnight (Figure 2b).
The RNAs obtained in the RNase protection reaction
are then excised from the gel and purified by the
soak-crush method.
(a)
(b)
(c)
(d)
Figure 3. Processing patterns of MBII-85 and MBII-52. (a and b) Schematic overview of the SNURF–SNRPN transcription unit. Exons are
indicated as vertical lines, snoRNAs are shorter vertical lines. The SNURF–SNRPN genes contains at least 11 exons and introns, which are
shown as one box for simplicity. The three arrows underneath the gene structure indicate three reported microdeletions that cause Prader-Willi
syndrome in humans (14–16). The thick black line indicates the deleted region common to all patients (i) reported in (15), ii reported in (14), and iii
reported in (16). (a) SNURF–SNRPN transcription unit in human, (b) SNURF–SNRPN transcription unit in mouse. (c) Sequences of the clones
obtained for MBII-85, expression unit chr7:66 838 324–66 844 003 on NCBI37/mm9. C/D box snoRNA elements are indicated by colored boxes and
terminal stems underlined. The notation a–f refers to Figure 2b. (d) Comparison of the processing sites in the structures of MBII-52 and MBII-85.
The C/D box typical sequence elements are indicated (AS: antisense box, C, D, C0, D0 boxes). Arrows point to the major processing sites. Letters
next to the arrows indicate the psnoRNA forms generated by this processing, which could be either an endonuclease cleaving site or a protecting
point for an exonuclease.
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Next, we add 30 linkers to the dsRNAs obtained during
the RNase protection reaction. Each RNase-protection
signal consists of two dsRNA strands: one strand is
derived from the endogenous RNA and the other one
comes from the added in vitro generated antisense RNA.
Although the strands are separated in the 8M urea acryl-
amide gel used for the protection analysis, due to their
small size the RNAs will reanneal during elution from
the gel. We could not add conventional RNA oligonucleo-
tides to these RNAs using different RNA and DNA
ligases (data not shown), which could account for
previous failures to clone protected fragments. However,
the use of pre-activated 50 adenylated (rApp) oligonucleo-
tides turned out to be highly efficient. 50 adenylated (rApp)
oligonucleotides are similar to the intermediate oligo-
nucleotide during a ligation reaction, where the ligase
adds rATP to the 50-end of the nucleic acid, which is sub-
sequently removed during the ligation (17). The 30 linker
added to the dsRNA contains a ddC at the 30-end to
prevent self-ligation (Figure 1b).
As shown in Figure 2c, the addition of the 50 adenylated
linker is highly efficient, as the protected fragments show
the expected shift in mobility, caused by the additional
linker sequence. After linker ligation, the RNAs are
phosphorylated using polynucleotide kinase, purified by
phenol–chloroform reaction and precipitated. The 50
phosphorylated RNAs with the ligated 30 linker are
purified a second time using an 8M urea/TBE polyacryl-
amide gel. We found that this step is essential, as otherwise
residual short (1–5 nt) oligonucleotides ligate to the second
linker and are preferentially amplified in the following
PCR steps.
Next, we ligate the 50-linker using T4 DNA ligase at
20C overnight. To aid in ligation, the 50-linker is partially
complementary to the 30 linker, and generates a Y-shaped
structure in the final product (Figure 1b). The RNA with
linkers is then reverse transcribed using a reverse tran-
scriptase that works at 60C. The synthesis of the first
cDNA strand is monitored by incorporation of 32P
a-dCTP in the reverse transcription reaction, as shown
in Figure 2d. The obtained cDNA reflects the length dis-
tribution of the input RNA, indicating that full-length
cDNA can be obtained by reverse transcription of
dsRNAs, when a reverse transcriptase acting at higher
temperature is used.
The obtained cDNA fractions are amplified by PCR
and subcloned into topoisomerase-activated vectors
(Invitrogen). Bacteria containing MBII-85 fragments were
identified by colony hybridization. As shown in Figure 2e,
10–20% of the clones contained inserts derived from
MBII-85.
Structure of the processed MBII-85 snoRNAs
The sequences of the clones containing MBII-85 dsRNA
fragments are shown in Figure 3c. They account for the
protection pattern that we observed (Figure 2b). We next
compared the processing patterns of MBII-85 with the
patterns of MBII-52 that we determined earlier (3).
Classic C/D box snoRNAs have characteristic sequence
elements that determine the association of the full-length
snoRNA with protein complexes (18). The elements are
the C, D, C0 D0 boxes, a terminal stem with an RNA kink
and two antisense sequences. As shown in Figure 3d the
sites of processing are similar between MBII-52 and
MBII-85. The processing events occur in the stem of the
snoRNA, cut once in the antisense elements, and cut in the
C and D box. In both snoRNAs, the nuclease action leads
to specific processed RNA molecules, which suggests
RNase action, either by a selective endonuclease or by
exonucleases arrested at specific sites.
Although there is evidence from HTS data for abundant
processing of C/D box snoRNAs (19), it should be men-
tioned that not all C/D box snoRNAs are processed. For
example, we cannot detect fragmentation of the U90
snoRNA using RNase protection (Supplementary Figure
S1a).
Comparison with traditional cloning methods for small
RNAs
Cloning efforts for miRNAs identified several fragments
that were derived from C/D box snoRNAs. Interestingly,
>80% of these shorter RNAs derived from C/D box
snoRNAs were flanked by D boxes (4). We observe similar
processing sites downstream of the D box in the stems and
upstream of the D0 box in the antisense region, indicating
that D-box sequences act during processing or have a
functional role in the resulting psnoRNAs (Figure 3D).
The RNA used to clone shorter C/D box snoRNA-
derived RNAs in HTS experiments was size selected to
cover the miRNA range (4,19). Therefore, larger C/D
box snoRNA fragments might have been missed.
Regarding MBII-85, we did not find any RNA in the
22-nt range typical for miRNAs (Figure 2b). This indi-
cates that the generation of miRNAs is not the major
function of this MBII-85 expression unit. It also suggests
that psnoRNAs are not made by dicer, which would
generate smaller RNA fragments.
In contrast to the fairly similar HBII-52 copies (3,20),
the 29 human HBII-85 snoRNA copies can be subgrouped
into three clusters based on their sequences. A
deep-sequencing analysis that counted overlapping reads
for each snoRNA showed different expression levels of
HBII-85 sequences in each cluster (21). The mouse
snoRNA copy that we analysed falls into the third cluster,
which shows the lowest expression. RNAs from the
MBII-85 cluster have been recently cloned from isolated
RNPs (22). In this method, non-coding RNAs are enriched
by isolating their protein particles. The single-stranded
RNA is then isolated and cloned. The cloning is per-
formed by traditional polyC tailing of the single-stranded
RNAs and by addition of 50-end linkers, followed by RT–
PCR. Sequences derived from this method showed a
strong bias towards highly expressed RNAs, correspond-
ing to the first human cluster (Supplementary Figure S1c).
Although several hundred reads corresponded to MBII-85
psnoRNAs in the dataset, the MBII-85 copy used in our
study was not present in the dataset, most likely as it is less
abundantly expressed. A bioinformatics analysis of the all
MBII-85 RNAs generated by cloning from RNPs shows
that the vast majority is derived from cutting MBII-85 in
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the second antisense box (Supplementary Figure S1b)
(C/F position, Figure 3c) and in the first antisense box (f
position, Figure 3c).
These data indicate that cloning RNA directly from
RNase protection fragments can be more sensitive than
deep-sequencing complete libraries of RNAs made by
conventional methods, especially when one particular
RNA is investigated.
Abundant expression of potentially dsRNAs in cellular
RNA samples
As shown in Figure 2e, even when we enriched for pro-
tected RNAs by cutting out the bands representing
the protected fragments, we obtained a high number
of clones containing non-related RNA sequences. To
obtain a complete picture of RNAs identified by our
cloning method, we analysed the obtained cDNAs by
HTS analysis using the SOLiDTM deep-sequencing
platform (23). The PCR fragments were directly ligated
to the solid support and subjected to sequencing.
HTS gave a total of 47 755 454 SOLiDTM reads of
length 50. We used used bowtie (11) to align them to the
mouse genome. The obtained reads could be mapped to
22 216 961 unique sites in the mouse genome, forming
14 171 215 clusters in both strands. Selecting those clusters
that are significantly close to each other and overlap by
>50% in both DNA strands, we found 164 033 double-
stranded clusters (see ‘Materials and Method’ section in
Supplementary Data S2.1 and Supplementary Figure S2).
Analysis of the distance between read clusters of more
than one read showed that they tend to occur at distances
<100 nt (Supplementary Figure S3). We therefore con-
sidered superclusters that were defined as read clusters
separated in the same strand by <100 nt (Supplementary
Figure S2c). Within these 4 800 821 forward and 4 801 075
reverse superclusters, there were 1 502 330 and 1 502 952
superclusters, respectively, containing more than one
cluster. From these, a total of 164 033 overlap in both
strands in >50% of their length (Supplementary Figure
S2d). These represent candidate dsRNA molecules, with
lengths of 129 nt (Supplementary Figure S4). We
consider these to be a conservative estimate of candidate
dsRNA regions.
These clusters that potentially represent naturally oc-
curring dsRNAs were approximately equally distributed
between known genes, (n=80672) and intergenic regions
(n=83361). Known genes were defined by RefSeq anno-
tation. The data indicate a strong enrichment of dsRNAs
in known gene regions (P< 2.2e–16 using the chi
square test; 2=530 938.4, df=1), (Supplementary
Figures S3–S5).
We next evaluated the possibility that the dsRNAs that
we cloned reflect naturally occurring dsRNA regions. We
first calculated which regions in the genome could give rise
to dsRNA sequences. We determined the pre-mRNA
regions from the RefSeq annotation that overlap with
antisense transcripts indicated by other RefSeqs and
spliced ESTs. We considering only ESTs with introns, as
EST sequences may appear reversed in the database.
Therefore, intronless ESTs may align to the wrong strand.
However, ESTs with introns can be correctly assigned to
a strand using as a guide the conserved splice-site
sequences.
Using these constrains, we obtained a total of 35 916
genomic regions that could generate dsRNAs. We
called these genome areas dsRNA expressing candidate
(DEC) regions (Supplementary Figure S6). The DEC
regions are visualized on the UCSC genome browser at
http://regulatorygenomics.upf.edu/Data/Cloning/.
We then determined how many of these DEC regions
contain cloned protected fragments. We found that 88.4%
of DECs overlap with the read clusters (70.5% with clus-
ters of more than one read). Moreover, 21% of DECs
overlap with 2.4% of our 164 033 candidate dsRNAs.
An example of this analysis is shown in Figure 4A for
the Dlgap2 gene that partially overlaps with the
AU016332/AU016667 transcript. The DEC regions were
not uniformly spread over all genes, but are concentrated
in certain genes. The top 10 genes with the highest amount
of cloned dsRNAs overlapping with DEC regions are
listed in Table 1. The genes with the highest number of
cloned dsRNAs are shown in Table 1.
Validation of dsRNA regions by RT–PCR
We next tested the existence of dsRNA transcripts with
RT-PCR as a different method. We selected primers com-
plementary to the end of dsRNAs for PCR. As templates,
we reverse transcribed the RNA with either the forward or
reverse primer. As shown in Figure 4B, we could amplify
cDNA with the expected size using either primer for most
of the tested dsRNAs. We did not observe amplification
without reverse transcription, indicating that we amplified
RNA. Since both the reverse and forward primers could
prime cDNA synthesis, the substrate was dsRNA.
The observed PCR products showed a weak intensity,
suggesting that the RNAs are not highly abundant,
which is expected, as these RNAs have not been cloned
by traditional methods. This experiment demonstrates
that our method detected novel double-stranded cellular
RNAs.
Since we used total mouse brain RNA for the hybrid-
ization, we cannot rule out that these double-stranded
clusters represent hybridization of two RNA strands
from different cells. However, several of the genes with
DEC regions are ubiquitously expressed in mouse brain,
for example Dlgap2, Maml3 and 2610528E23Rik/Filip1l.
It is therefore possible that within a single cell RNA can be
expressed from different DNA strands at the same locus.
We also do not know whether the RNA is derived from
the same or different alleles. However, since we observe
dsRNAs from the Y chromosome, it is possible that we
detected RNA expression from polymerase II acting in
different directions on a single DNA molecule.
It also remains to be determined whether these RNAs
interact in a physiological context, as they are likely
coated with proteins that are removed in the RNA prep-
aration. In all examples, we see gaps between the cloned
dsRNA within the longer bioinformatically predicted
DECs (Figure 4). This could indicate nuclease action on
Nucleic Acids Research, 2011, Vol. 39, No. 22 9727
dsRNAs that would destroy long dsRNAs formed in the
cell, analogous to dicer acting on pre-miRNAs.
DEC regions overlap with known argonaute-binding sites
Pre-miRNAs contain dsRNA regions. The dsRNAs are
cleaved by dicer and are loaded onto argonaute proteins
by the RISC complex. To test whether the experimentally
confirmed dsRNAs could be dicer substrates, we
compared our dsRNA clusters with experimentally con-
firmed argonaute-binding sites (12). Excluding reads in
repeat regions, we found that 10 454 of dsRNA clusters
overlap with Ago targets and 5665 overlap with Ago
miRNA reads. Supplementary Table S1 lists examples of
candidate dsRNA regions that overlap with known
miRNAs. This overlap strongly suggests that some of
the longer dsRNAs are processed by dicer and the result-
ing fragments loaded on argonautes. It is also possible
that dsRNA regions are markers for so far unknown
miRNA expressing regions.
Together, these data strongly suggests that within a cell
RNA:RNA interactions occur that can be determined by
our method. However, at this point we cannot discrimin-
ate between RNA:RNA interaction that occur within a
single cell and artificial interactions caused by the hom-
ogenization of the tissue and the mixing of all cellular
RNAs. Nevertheless, the candidate list of dsRNA
regions allows further detailed investigations of the
physiological role of dsRNAs.
DISCUSSION
Although RNase protection methods have been used for
over 30 years (24), there is no protocol available to clone
dsRNAs generated by these experiments. Typically, the
structure of the protected fragments is deduced indirectly
by their length. The method described here allows cloning
of small dsRNA amounts derived from such experiments.
The major problem in cloning protected fragments was
that the sense and antisense stands cannot be separated,
as they migrate identically through denaturing acrylamide
gels. Every subsequent biochemical manipulation requires
the removal of urea, which leads to re-annealing of the
RNA strands. As there are no known dsRNA ligases,
cloning of these fragments proved difficult.
There are two essential factors that allowed cloning of
dsRNAs: the use of adenylated linkers and rigorous gel
purification of intermediate products. DsRNAs with blunt
ends are poor substrates for RNA or DNA ligases.
However an adenylated linker that represents the
activated form of a single-stranded nucleic acid in a
ligation reaction can be efficiently ligated to the
dsRNAs. It is important that all free nucleotides are
removed prior to ligation as adenylated linkers preferen-
tially react with their free 30 hydroxyl groups.
The method has several advantages over current cloning
procedures. First, there is no knowledge of priming sites
necessary, which allows it to be applied to non-coding
RNAs or mRNA fragments. Secondly, the antisense
probe strand that was generated in vitro contains no
(a)
(b)
Figure 4. Visualization and detection of cloned protected fragments in putative dsRNA regions. (a) The protected fragments are visualized as a tract
in the UCSC genome browser. The Dlgap2 gene partially overlaps with the AU016332/AU016667 transcript, which defines a DEC region. (b) RT–
PCR analysis of dsRNAs in DEC regions. C, no reverse transcription; F, only the forward primer was used for reverse transcription; R, only the
reverse primer was used for reverse transcription. Note that we could not detect amplification with Maml3, primer2 and Rik, primer 2 indicating low
dsRNA expression. The tracks can be seen at http://regulatorygenomics.upf.edu/Data/Cloning/.
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modified nucleotides, such as a 50 cap or 20,30-cyclic phos-
phates that prevent linker ligation. Together, this allows
cloning of highly modified unknown RNAs.
As the method detects a specific RNA that is enriched
through the RNase protection procedure, it can be more
sensitive for a specific intermediate than HTS.
Unexpectedly, we found that dsRNAs generated by
natural antisense RNAs are very abundant in RNase pro-
tection experiments. A cross-interaction with such en-
dogenous dsRNAs could account for RNase protection
artifacts that are sometimes observed. Our bioinformatic
analysis indicated that the majority of these dsRNAs are
derived from genomic regions that show evidence for anti-
sense expression. As some of these regions show wide-
spread expression throughout the brain, it is likely that
some antisense expression occurs in the same cells. We
observed that dsRNAs from these regions are processed
into smaller fragments. A cleavage of such longer dsRNAs
would be similar to the cleavage of stems–loop structures
found in conventional pre-miRNAs by dicer. Since RNAs
derived from these dsRNAs could be mapped to
argonaute-binding sites, it is possible that dsRNAs
generated by antisense expression give rise to miRNAs.
It was shown that dsRNAs can be exported from the nu-
cleus to the cytosol by HIV-REV (25). It is thus possible
that an endogenous cellular pathway exists that exports
dsRNAs into the cytosol, where they form the substrate of
miRNA formation.
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